CompaniesCytoPharm

CytoPharm

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

0

As Collaborator

2

Total Enrollment

209

By Phase

PHASE2: 2

By Status

COMPLETED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2008
2009
2010
2011
2012
2013
Today
NCT00695019
NCT01146535
Hover over trial bars to see details

Recent Trials

NCT01146535Collaborator
Interferon Alpha Lozenges Plus Oseltamivir for Influenza Treatment
PHASE2Completed
40 participants
Started: Jan 31, 2011 · Completed: Dec 31, 2012
NCT00695019Collaborator
Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C
PHASE2Completed
169 participants
Started: Jun 30, 2009 · Completed: Feb 29, 2012